Quiets your appetite
Semaglutide mimics GLP-1, a natural fullness hormone your gut releases when you eat, reducing hunger and turning down cravings between meals.
Available now · the first oral GLP-1
The Wegovy Pill, from £94.
A once-daily tablet with the same active ingredient as the Wegovy injection, now MHRA approved in the UK — and the same clinician-led care as the rest of Curate. A 5-minute consultation, no needles, no subscription.
Choose your daily dose
From£9430-day supply · one-time purchase
Start consultation · 5 minOrder today · every dose in stock
Complete your consultation today. Every dose of the Wegovy Pill is in stock and dispatches in discreet packaging once a clinician approves your order. You pay after your consultation and are refunded in full if it’s not right for you.
- GPhC pharmacy 9012920
- CQC-regulated prescribing
- No subscription
How it works
The injection’s results, without the pen.
Semaglutide is a GLP-1 receptor agonist, mimicking a hormone your gut already makes. The tablet works the same way as the weekly jab, just delivered orally.
Slows digestion
Food leaves your stomach more gradually, so you feel genuinely satisfied with smaller portions. Less restriction, more off-switch.
Steadies blood sugar
The same pathway helps your body manage blood sugar levels, supporting steadier energy alongside the weight loss itself.
Getting started
From consultation to your door.
Three short steps stand between you and the UK’s first oral GLP-1 — and you can complete the first one in five minutes.
Start your consultation
A 5-minute online consultation about your health and goals. No GP referral, no waiting room.
A clinician reviews
A UK-registered clinician checks the pill is right for you. If it isn't, you're refunded in full.
Delivered to your door
Once approved, your treatment is dispatched in discreet, plain packaging — with your care team a message away whenever you need them.
- average weight loss over 64 weeks at the full dose*
- 16.6%
- lost 20% or more of their body weight in the same trial
- 1 in 3
- approved as the UK's first oral GLP-1 for weight loss
- MHRA
- one tablet each morning, swallowed whole
- Daily
*OASIS 4 trial: oral semaglutide 25 mg alongside a reduced-calorie diet and increased activity. Individual results vary.
Dosing
Built up gently, never rushed.
Four strengths, stepped up every 30 days so your body can adjust and side effects stay manageable. Your prescriber sets the pace, and can hold a dose longer whenever that’s the right call.
| Dose | Duration | Stage |
|---|---|---|
| 1.5 mg once daily | Days 1–30 | Starting dose |
| 4 mg once daily | Days 31–60 | Work your way up |
| 9 mg once daily | Days 61–90 | Work your way up |
| 25 mg once daily | Days 90 onwards | Maximum dose |
Transparent pricing
Once-a-day treatment pricing.
A one-off price, not a subscription. You pay when you order; if a UK-registered clinician decides treatment isn't right for you, you're refunded in full.
WELCOME35£35 off your first month
The oral tablet steps up over time. Your clinician sets the pace and the right dose for you.
| Daily dose | Price |
|---|---|
| 1.5mg | £94 / 30 days |
| 4mg | £97 / 30 days |
| 9mg | £109 / 30 days |
| 25mg | £154 / 30 days |
Eligibility
Is treatment suitable for you?
Your BMI29.0Overweight
You may be eligible
Treatment can be appropriate at this BMI if you also have a weight-related health condition. A clinician reviews your full picture before deciding.
Your BMI is a screening estimate for eligibility, not a diagnosis. Once you have completed your online consultation, a clinician will review your health profile. This will determine whether treatment is right for you.
How it compares
Pill or pen? Know the trade-off.
The injections edge ahead on trial results; the pill wins on fitting quietly into a morning routine. Whichever you lean towards, a clinician helps you decide.
| Wegovy Pill | Wegovy | Mounjaro | |
|---|---|---|---|
| Active ingredient | Semaglutide | Semaglutide | Tirzepatide |
| How it's taken | Daily tablet | Weekly injection | Weekly injection |
| Hormones targeted | GLP-1 | GLP-1 | GLP-1 + GIP |
| Average weight loss* | 16.6% · 64 wks | 20.7% · 72 wks | 21% · 72 wks |
| UK approved | Yes | Yes | Yes |
*Average body-weight change at the highest approved dose in separate clinical trials (OASIS 4; STEP UP; SURMOUNT-1), not head-to-head comparisons. Individual results vary.
Why people choose Curate
Quietly looked after, start to finish.
The team genuinely couldn't be more helpful — every question answered within hours, no judgement, just proper support whenever I needed it.
Curate patient · 9 months
Ordered in the evening and it arrived two days later in plain packaging. The whole process was quicker and easier than I ever expected.
Curate patient · 4 months
I've felt looked after the whole way through. Friendly clinicians, clear pricing, and a care team that actually checks in on how you're doing.
Curate patient · 6 months
Who it suits
Made for the needle-averse.
- You'd rather take a daily tablet than a weekly injection
- Needles are the thing that's been putting you off treatment
- You've had injection-site reactions on Wegovy or Mounjaro
- You've reached your goal weight and want a maintenance option
FAQs
Your questions, answered.
The essentials on the Wegovy Pill. Anything else, our team is happy to help.
Still have questions? Talk to our team
How quickly can I start?
You can complete the online consultation today — it takes about five minutes — and a UK-registered clinician reviews it, usually within 48 hours. Every dose is in stock, so once approved, your first month is dispatched in discreet, plain packaging.
What's included in the price?
Your treatment, unlimited clinical messaging, clinician reviews and dose adjustments, and pharmacist support — all included. No appointment fees, no add-ons.
What if treatment isn't right for me?
A UK-registered clinician reviews your full health history before anything is dispensed. You pay when you order, but if they decide the pill isn't appropriate for you, you're refunded in full.
How much weight could I lose?
In the OASIS 4 trial, adults taking the 25 mg dose lost 16.6% of their body weight on average over 64 weeks, alongside a reduced-calorie diet and increased activity. Around 1 in 3 lost 20% or more. Individual results vary.
Is the pill as effective as the injections?
The injections currently edge ahead in trial results: around 20.7% average weight loss for Wegovy and 21% for Mounjaro at the highest doses, against 16.6% for the pill. The pill wins on convenience if needles are holding you back. A clinician can help you weigh up which suits you.
Is this a subscription?
No — it's a one-time purchase, not a plan you're locked into, and you're never auto-billed. Once you order, we support you through your course of treatment.
How do I take it?
One tablet each morning on an empty stomach, swallowed whole with up to 120 ml of water. You then wait 30 minutes before eating, drinking or taking other oral medicines.
Advice & guides
Weight loss, explained properly.
Weight Loss
Am I eligible for the Wegovy pill? BMI and criteria explained
Eligibility for oral semaglutide rests on BMI, weight-related conditions and your wider health. How the criteria work, and what an assessment actually checks.
Weight Loss
What to eat on the Wegovy pill
The tablet adds a food-timing rule no injection has, and a smaller appetite raises the stakes on what fills it. A practical eating guide for oral semaglutide.
Weight Loss
Can you take the Wegovy pill at night?
Mornings do not suit everyone. Whether night-time dosing of oral semaglutide can work, what the absorption rules demand, and how shift workers can manage.
Available now · from £94
Weight loss, in a once-daily tablet. Order today.
A 5-minute consultation, a UK-registered clinician’s review, and a full care team behind you — no needles, no subscription.
Start consultation · 5 minYou pay when you order, after your consultation, and are refunded in full if treatment isn’t right for you. Every dose is in stock and dispatches in discreet, plain packaging once approved.
References
- Wharton S, et al. Oral semaglutide 25 mg in adults with overweight or obesity (OASIS 4). New England Journal of Medicine, 2025.
- Wharton S, et al. Efficacy and safety of semaglutide 7.2 mg in obesity (STEP UP). Diabetes, 2025.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 2022.